Approval · Notice of Compliance 25246 · 2021
CLOPIDOGREL: Notice of Compliance 25246
Issued February 18, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25246
- Date
- February 18, 2021
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Reason
- Updated labelling materials and licensing agreement between two companies
- Canadian reference product
- PLAVIX (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLOPIDOGREL | 02400553 | Marketed |
Medicinal ingredients
- CLOPIDOGREL BISULFATE 97.9 MG per TAB